RPS 2211 - Contrast agents and energy sustainability in neuroimaging

Efficacy of gadoquatrane, a novel low-dose high relaxivity macrocyclic gadolinium-based contrast agent, at 5-, 10- and 15-min post injection in comparison to gadobutrol for CNS CE-MRI

Clinical experience with gadopiclenol in patients with brain metastases: Single and double doses, comparison of standard and delayed scanning

Global body exposure to gadolinium after administration of the Human Equivalent Dose (HED) of gadopiclenol, in comparison to the HED of gadobutrol and gadoterate in Healthy Rats

Use of gadolinium-based contrast agents (GBCA) over the years: impact on monitoring multiple sclerosis disease activity

Different rates and patterns of symptoms associated with gadolinium exposure (SAGE) between linear and macrocyclic gadolinium based contrast agents

Synthetic MRI Derived Relaxometry Parameters: A New Insight into Characterization of Ring Enhancing Lesions of Brain

How Compressed-Sense acceleration technique impacts the Central Nervous System Magnetic Resonance Imaging energy consumption

A methodology for reducing the environmental impact of the energy consumption of a neuroradiology MRI system using daily electricity emission data